Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019621 (
Langerhans cell histiocytosis
)
3,250
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
There is little information available regarding epidemiologic risk factors for
Langerhans cell histiocytosis
(
LCH
). An exploratory investigation was conducted using information obtained from parents of 177 cases of
LCH
diagnosed before 21 years of age (median 2 years). Utilizing data available from the Children's Cancer Group,
LCH
cases were compared to two matched control groups including 614 patients diagnosed with a variety of childhood cancers and 318 community controls. Questionnaire data included information on demographics, prenatal and perinatal factors, complications in the neonatal period, environmental exposures, family medical history, and childhood exposures. Factors found to be statistically significantly associated with an increased risk of
LCH
included: maternal
urinary tract infection
during the index pregnancy, feeding problems during infancy, and blood transfusions during infancy. Use of supplemental vitamins was associated with a significantly decreased risk of
LCH
. Results from this exploratory study provide a basis for speculation on potential etiologic risk factors for
LCH
. Future epidemiologic investigations of
LCH
need to consider the presenting disease characteristics in assessing possible etiologic factors.
...
PMID:Langerhans cell histiocytosis: an exploratory epidemiologic study of 177 cases. 898 44
Erdheim-Chester disease is a rare non-
Langerhans cell histiocytosis
characterized by progressive histiocytic proliferation with multiorgan involvement, typically of the kidney, skin, brain, and lung, and less frequently, the heart and retro-orbital tissue. Fluorine-18 fluorodeoxyglucose positron emission tomography (F-18 FDG PET) plays an important role in the management of this disease. It has been reported that FDG PET imaging allows accurate evaluation of the extent of the disease at baseline, as well as assessment of response to any specific therapy. In this case, a 57-year-old Chinese man presented with functional decline and a
urinary tract infection
. He had a prior history of xanthogranulomas of bilateral canthal masses. On imaging, he was found to have left hydronephrosis, diffuse urothelial thickening, increased density of the perinephric fat, mural thickening of the descending aorta and soft tissue masses along the posterior wall of the right atrium extending into the region of the interatrial septum and involving the right atrioventricular groove. Histopathology revealed retroperitoneal fibrosis. An IV contrast-enhanced FDG PET scan showed increased activity in a previously unidentified brain stem mass and the shafts of bilateral femora. Varying levels of FDG uptake were seen in the other lesions.
...
PMID:Intensely hypermetabolic extra-axial brainstem tumor in Erdheim-Chester disease. 1969 24